Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emotion in advertising

This article was originally published in The Tan Sheet

Executive Summary

Advertisers should craft ads around creativity and emotion and not factual content to build strong brand relationships, a study published in the December issue of Journal of Advertising Research finds. "High attention weakens the effect of emotional content," so ads might be more effective "processed at lower levels of attention," report Robert Heath, School of Management, University of Bath, UK, et al. The authors worked with research firm OTX to assess the rational and emotional content of 23 U.S. on-air ads and 20 in the UK. They then surveyed 200 people in each country to gauge their responses to the featured brands. "The results confirm that favorability towards brands is strongly correlated with emotional content in advertising, but not with factual content," Heath states, adding that subtle emotional elements are more likely to work "because the viewer has less opportunity to rationally evaluate, contradict and weaken their potency"...

You may also be interested in...



Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100048

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel